Skip to content
Screener

Hubbell HUBB Number of joint ventures

Number of joint ventures at other companies

NVR logo
NVRNVR
4-20.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$20.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
20.0%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$2
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
2
Flowserve logo
FlowserveFLS
10.0%

Other financials

Income statement

See full
Revenue$1.7B+15.3%
Gross profit$613.0M+11.0%
Operating income$348.6M+3.7%
Net income$240.4M-1.6%
EPS (diluted)$4.52-0.9%

Balance sheet

See full
Cash & equivalents$378.6M-1.0%
Total debt$5.0B+316%
Total equity$3.9B+12.2%
Total assets$11.8B+65.7%

Cash flow

See full
Operating cash flow$249.8M-4.1%
CapEx$37.0M-7.3%
Free cash flow$212.8M-3.6%

Valuation

See full
Market cap$27.13B+20.5%
Enterprise value$31.74B+36.1%
P/E30.1×+2.8×
P/S4.4×+0.4×

Profitability

See full
Gross margin35.2%+0.6pp
Operating margin20.2%-0.1pp
Net margin14.5%-0.2pp
FCF margin14.5%+0.5pp

Returns & leverage

See full
Return on equity24.4%-0.9pp
Debt / equity1.3×+0.9×
Current ratio1.6×+0.3×

Where this comes from

Reported directly by Hubbell in its filing.

Tagged under the XBRL concept hubb:NumberOfJointVentures.

The source filing: Hubbell’s 10-K, filed February 12, 2026.

Filed
Feb 12, 2026, 8:21 AM EST
Fiscal year
FY2025
Accession
0001628280-26-007500

The Consolidated Financial Statements include all wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The Company participates in two joint ventures that have been consolidated in accordance with the consolidation accounting guidance. An analysis is performed to determine which reporting entity, if any, has a controlling financial interest in a variable interest entity (“VIE”) with a primarily qualitative analysis. The qualitative analysis is based on identifying the party that has both the power to direct the activities that most significantly impact the VIE’s economic performance (the “power criterion”) and the obligation to absorb losses from or the right to receive benefits of the VIE that could potentially be significant to the VIE (the “losses/benefit criterion”). The party that meets both these criteria is deemed to have a controlling financial interest. The party with the controlling financial interest is considered to be the primary beneficiary and as a result is required to consolidate the VIE. The Company has a 50% interest in a joint venture in Hong Kong, established as Hubbell Asia Limited (“HAL”). The principal objective of HAL is to manage the operations of its wholly-owned manufacturing company in China. Under the accounting guidance, the Company is the primary beneficiary of HAL and as a result consolidates HAL.

ITEM 8 Financial Statements and Supplementary Data

FAQ

What is Hubbell's number of joint ventures?
Hubbell (HUBB) reported number of joint ventures of 2 in Q4 2025.
How has Hubbell's number of joint ventures changed year-over-year?
Hubbell's number of joint ventures decreased by 0.0% year-over-year, from 2 to 2.
What is the long-term trend for Hubbell's number of joint ventures?
Over 4 years (2021 to 2025), Hubbell's number of joint ventures has grown at a 0.0% compound annual growth rate (CAGR), from 2 to 2.
What does number of joint ventures mean?
This metric tracks the total number of active joint ventures in which the company participates. Joint ventures are strategic partnerships where the company shares control and risks with another entity to pursue specific business opportunities. This provides insight into the company's strategy for market expansion, technology sharing, or risk mitigation.

Ask your AI about Hubbell's number of joint ventures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude